These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1269216)

  • 21. Tocainide: a new drug for ventricular arrhythmias.
    Volosin KJ; Greenspon AJ
    Am Fam Physician; 1986 Jan; 33(1):233-5. PubMed ID: 3079938
    [No Abstract]   [Full Text] [Related]  

  • 22. Disposition of intravenous pirmenol.
    Sanders SW; Nappi JM; Foltz RL; Lutz JR; Anderson JL
    J Clin Pharmacol; 1983; 23(2-3):113-22. PubMed ID: 6853743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of tocainide in acute myocardial ischaemia.
    Sutton PP
    Br J Clin Pharmacol; 1980 Nov; 10(5):530-1. PubMed ID: 6776976
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of oral sustained release clonidine in humans.
    MacGregor TR; Relihan GL; Keirns JJ
    Arzneimittelforschung; 1985; 35(1A):440-6. PubMed ID: 4039184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-arrhythmic effect of tocainide (lidocaine congener) on ventricular arrhythmias (author's transl)].
    Kuck KH; Hanrath P; Lubda J; Mathey D; Bleifeld W
    Dtsch Med Wochenschr; 1979 Nov; 104(48):1701-5. PubMed ID: 93043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of tocainide in the rat.
    Venkataramanan R; Abbott FS; Axelson JE
    J Pharm Sci; 1982 May; 71(5):491-4. PubMed ID: 6808112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of rifampin on tocainide pharmacokinetics in humans.
    Rice TL; Patterson JH; Celestin C; Foster JR; Powell JR
    Clin Pharm; 1989 Mar; 8(3):200-5. PubMed ID: 2495879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of trospium chloride.
    Doroshyenko O; Jetter A; Odenthal KP; Fuhr U
    Clin Pharmacokinet; 2005; 44(7):701-20. PubMed ID: 15966754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition and antiarrhythmic effect of lorcainide.
    Klotz U; Müller-Seydlitz P; Heimburg P
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):152-8. PubMed ID: 376458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gas chromatographic assay for tocainide carbamoyl-O-beta-D-glucuronide:quantitation of the base hydrolyzed product, 3-(2',6'-xylyl)-5-methylhydantoin.
    Kwok DW; McErlane KM; Axelson JE
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):395-409. PubMed ID: 2111573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetics of some antiarrhythmic drugs.
    Ochs HR; Greenblatt DJ; Bodem G
    Herz; 1979 Aug; 4(4):330-43. PubMed ID: 391683
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
    Klotz U; Müller-Seydlitz P; Heimburg P
    Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Furosemide kinetics in renal failure.
    Tilstone WJ; Fine A
    Clin Pharmacol Ther; 1978 Jun; 23(6):644-50. PubMed ID: 648078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline.
    Canal M; Flouvat B; Tremblay D; Dufour A
    Eur J Clin Pharmacol; 1983; 24(4):509-15. PubMed ID: 6861865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of lidocaine and its deethylated metabolite: dose and time dependency studies in man.
    Bennett PN; Aarons LJ; Bending MR; Steiner JA; Rowland M
    J Pharmacokinet Biopharm; 1982 Jun; 10(3):265-81. PubMed ID: 7175699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absolute quinidine bioavailability.
    Ueda CT; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Sep; 20(3):260-5. PubMed ID: 954347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response optimization of drug dosage: antiarrhythmic studies with tocainide.
    Meffin PJ; Winkle RA; Blaschke TF; Fitzgerald J; Harrison DC; Harapat SR; Bell PA
    Clin Pharmacol Ther; 1977 Jul; 22(1):42-57. PubMed ID: 872495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis and stereoselective metabolism after separate oral doses of tocainide enantiomers to healthy volunteers.
    Hoffmann KJ; Renberg L; Gyllenhaal O
    Biopharm Drug Dispos; 1990; 11(4):351-63. PubMed ID: 2111189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics and bioavailability of mexiletine in healthy subjects.
    Häselbarth V; Doevendans JE; Wolf M
    Clin Pharmacol Ther; 1981 Jun; 29(6):729-36. PubMed ID: 7226704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.